Best Practice & Research Clinical Gastroenterology, 2016, 30 (1), 119–131.
Diet and cancer. https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/diet-and-cancer
Gopalakrishnan V., Spencer C. N., Nezi L., Reuben A., Andrews M. C., Karpinets T. V., Prieto P. A., Vicente D., Hoffman K., Wei S. C., Cogdill A. P., Zhao L., Hudgens C. W., Hutchinson D. S., Manzo T., Petaccia de Macedo M., Cotechini T., Kumar T., Chen W. S., Reddy S. M. & others. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients // Science, 2018, 359 (6371), 97–103.
Greenwald P., Clifford C. K., Milner J. A., Eur J. Diet and cancer prevention // Cancer, 2001, 37 (8), 948–965.
Kelly C. R., Kahn S., Kashyap P., Laine L., Rubin D., Atreja A., Moore T., Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook // Gastroenterology, 2015, 149 (1), 223–237.
Martinez-Outschoorn U. E., Peiris-PagЕs M., Pestell R. G., Sotgia F., Lisanti M. P. Cancer metabolism: a therapeutic perspective // Nature Reviews Clinical Oncology, 2017, 14 (1), 11–31.
Ostrander G. K., Cheng K. C., Wolf J. C., Wolfe M. J. Shark cartilage, cancer and the growing threat of pseudoscience // Cancer Research, 2004, 64 (23), 8485–8491.
Perez P. F., DorЕ J., Leclerc M., Levenez F., Benyacoub J., Serrant P., Segura-Roggero I., Schiffrin E. J., Donnet-Hughes A. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? // Pediatrics, 2007, 119 (3), 724–732.
Schwabe R. F., Jobin C. The microbiome and cancer // Nature Reviews Cancer, 2013, 13 (11), 800–812.
Van Der Weyden M. B., Armstrong R. M., Gregory A. T. The 2005 Nobel Prize in physiology or medicine // The Medical Journal of Australia, 2005, 183 (11–12), 612–614.
Vander Heiden M. G., Cantley L. C., Thompson C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation // Science, 2009, 324 (5930), 1029–1033.
Umar A., Dunn B. K., Greenwald P. Future directions in cancer prevention // Nature Reviews Cancer, 2012, 12 (12), 835–848.
Циммер К. Паразит — царь природы. Тайный мир самых опасных существ на Земле. — М.: Альпина нон-фикшн, 2012.
Bosman F. T., Stamenkovic I. Functional structure and composition of the extracellular matrix // The Journal of Pathology, 2003, 200 (4), 423–428.
Bussard K. M., Mutkus L., Stumpf K., Gomez-Manzano C., Marini F. C. Tumor-associated stromal cells as key contributors to the tumor microenvironment // Breast Cancer Research, 2016, 18 (1), p. 84.
Chaffer C. L., Weinberg R. A. A perspective on cancer cell metastasis // Science, 2011, 331 (6024), 1559–1564.
Cuzick J., Otto F., Baron J. A., Brown P. H. & others. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement // The Lancet Oncology, 2009, 10 (5), 501–507.
Dvorak H. F. Tumors: Wounds That Do Not Heal. Similarities Between Tumor Stroma Generation and Wound Healing // The New England Journal of Medicine, 1986, 315 (26), 1650–1659.
Folkman J. Role of angiogenesis in tumor growth and metastasis // Seminars in Oncology, 2002, (6 Suppl 16), 15–8.
Franzetti G. A., Laud-Duval K., van der Ent W., Brisac A., Irondelle M., Aubert S., Dirksen U., Bouvier C., de Pinieux G., Snaar-Jagalska E., Chavrier P., Delattre O. Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells // Oncogene, 2017, 36 (25), 3505–3514.
Frantz C., Stewart K. M., Weaver V. M. The extracellular matrix at a glance // Journal of Cell Science, 2010, 123 (Pt 24), 4195–4200.
Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J. F., Harrington K., Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells // Nature Cell Biology, 2007, 9 (12), 1392–1400.
Kalluri R. The biology and function of fibroblasts in cancer // Nature Reviews Cancer, 2016, 16 (9), 582–598.
Kaplan R. N., Riba R. D., Zacharoulis S., Bramley A. H. & others. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche // Nature, 2005, 438 (7069), 820–827.
Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment // Cell, 2010, 141 (1), 52–67.
Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation // Nature, 2008, 454 (7203), 436–444.
Nelson C. M., Bissell M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer // Annual Review of Cell and Developmental Biology, 2006, 22, 287–309.
Pachmayr E., Treese C., Stein U. Underlying Mechanisms for Distant Metastasis — Molecular Biology // Visceral Medicine, 2017, 33 (1), 11–20.
Peinado H., Lavotshkin S., Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts // Seminars in Cancer Biology, 2011, 21 (2), 139–146.
Rich R. M., Rosenfeld P. J., Puliafito C. A., Dubovy S. R. & others. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration // Retina, 2006, 26 (5), 495–511.
Yang J., Weinberg R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis // Developmental Cell, 2008, 14 (6), 818–829.
Терапевтические антитела. Спецпроект электронного журнала «Биомолекула». https://biomolecula.ru/specials/antitela.
Ярилин А. А. Иммунология. — М.: ГЭОТАР-Медиа, 2010.
Blum J. S., Wearsch P. A., Cresswell P. Pathways of antigen processing // Annual Review of Immunology, 2013, 31, 443–473.
Bottazzi B., Riboli E., Mantovani A. Aging, inflammation and cancer // Seminars in Immunology, 2018, 40, 74–82.
June C. H., O’Connor R. S., Kawalekar O. U., Ghassemi S., Milone M. C. CAR T cell immunotherapy for human cancer // Science, 2018, 359 (6382), 1361–1365.
Kucerova P., Cervinkova M. Spontaneous regression of tumour and the role of microbial infection — possibilities for cancer treatment // Anticancer Drugs, 2016, 27 (4), 269–277.
Liu J. K. The history of monoclonal antibody development — Progress, remaining challenges and future innovations // Annals of Medicine and Surgery (Lond), 2014, 3 (4), 113–116.
Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity // Current Opinion in Immunology, 2010, 22 (2), 231–237.
Murchison E. P. Clonally transmissible cancers in dogs and Tasmanian devils // Oncogene, 2008, 27, 19–30. Papac R. J. Spontaneous regression of cancer // Cancer Treatment Reviews, 1996, 22 (6), 395–423.
Murgia C., Pritchard J. K., Kim S. Y., Fassati A., Weiss R. A. Clonal origin and evolution of a transmissible cancer // Cell, 2006, 126 (3), 477–487.
Pardoll D. M. The blockade of immune checkpoints in cancer immunotherapy // Nature Reviews Cancer, 2012, 12 (4), 252–264.
Rashidi A., Fisher S. I. Spontaneous remission of acute myeloid leukemia // Leukemia & Lymphoma, 2015, 56 (6), 1727–1734.
Reeves E., James E. Antigen processing and immune regulation in the response to tumours // Immunology, 2017, 150 (1), 16–24.
Schreiber R. D., Old L. J., Smyth M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion // Science, 2011, 331 (6024), 1565–1570.
Syn N. L., Teng M. W. L., Mok T. S. K., Soo R. A. De-novo and acquired resistance to immune checkpoint targeting // The Lancet Oncology, 2017, 18 (12), e731 — e741.
Vesely M. D., Kershaw M. H., Schreiber R. D., Smyth M. J. Natural innate and adaptive immunity to cancer // Annual Review Of Immunology, 2011, 29, 235–271.
Barabasi A. L., Oltvai Z. N. Network biology: understanding the cell's functional organization // Nature Reviews Genetics, 2004, 5 (2), 101–113.
Evidence-based medicine. https://en.wikipedia.org/wiki/Evidence-based_medicine.
Hood L., Friend S. H. Predictive, personalized, preventive, participatory (P4) cancer medicine // Nature Reviews Clinical Oncology, 2011, 8 (3), 184–187.
Kaitin K. I. Deconstructing the drug development process: the new face of innovation // Clinical Pharmacology & Therapeutics, 2010, 87 (3), 356–361.
Luo J., Wu M., Gopukumar D., Zhao Y. Big Data Application in Biomedical Research and Health Care: A Literature Review // Biomedical Informatics Insights, 2016, 8, 1–10.
Masic I., Miokovic M., Muhamedagic B. Evidence based medicine — new approaches and challenges // Acta Informatica Medica, 2008, 16 (4), 219–225.
Sackett D. L., Rosenberg W. M., Gray J. A., Haynes R. B., Richardson W. S. Evidence based medicine: what it is and what it isn’t // British Medical Journal, 1996, 312 (7023), 71–72.
The Drug Development Process (FDA). https://www.fda.gov/forpatients/approvals/drugs/